These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9150125

  • 1. Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation.
    Clements PJ, Furst DE.
    J Rheumatol Suppl; 1997 May; 48():85-8. PubMed ID: 9150125
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, Larghero J, Gluckman E, Preijers FW, van Dijk AP, Bax JJ, Roblot P, van Riel PL, van Laar JM, Farge D.
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations.
    Henes JC, Schmalzing M, Vogel W, Riemekasten G, Fend F, Kanz L, Koetter I.
    J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352
    [Abstract] [Full Text] [Related]

  • 6. Autologous stem cell transplantation for systemic sclerosis.
    Farge D, Nash R, Laar JM.
    Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
    [Abstract] [Full Text] [Related]

  • 7. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.
    Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, Peter HH, Breedveld FC, Fibbe WE, Black C, Denton C, Koetter I, Locatelli F, Martini A, Schattenberg AV, van den Hoogen F, van de Putte L, Lanza F, Arnold R, Bacon PA, Bingham S, Ciceri F, Didier B, Diez-Martin JL, Emery P, Feremans W, Hertenstein B, Hiepe F, Luosujärvi R, Leon Lara A, Marmont A, Martinez AM, Pascual Cascon H, Bocelli-Tyndall C, Gluckman E, Gratwohl A, Tyndall A, EBMT/EULAR Registry.
    Ann Rheum Dis; 2004 Aug; 63(8):974-81. PubMed ID: 15249325
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosis.
    van Laar JM, McSweeney PA.
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):233-45. PubMed ID: 15302337
    [Abstract] [Full Text] [Related]

  • 10. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
    Brinkman DM, de Kleer IM, ten Cate R, van Rossum MA, Bekkering WP, Fasth A, van Tol MJ, Kuis W, Wulffraat NM, Vossen JM.
    Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
    [Abstract] [Full Text] [Related]

  • 11. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK, Milanetti F.
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [Abstract] [Full Text] [Related]

  • 12. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.
    Oyama Y, Barr WG, Statkute L, Corbridge T, Gonda EA, Jovanovic B, Testori A, Burt RK.
    Bone Marrow Transplant; 2007 Sep; 40(6):549-55. PubMed ID: 17646844
    [Abstract] [Full Text] [Related]

  • 13. Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index.
    Fanin R, Silvestri F, Geromin A, Infanti L, Sperotto A, Cerno M, Stocchi R, Savignano C, Rinaldi C, Damiani D, Baccarani M.
    Bone Marrow Transplant; 1998 Feb; 21(3):263-71. PubMed ID: 9489649
    [Abstract] [Full Text] [Related]

  • 14. Stem cell transplantation in systemic sclerosis: rationale and status report.
    Furst DE, Tyndall A.
    Isr Med Assoc J; 2000 Dec; 2(12):935-7. PubMed ID: 11344779
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stem cell transplantation: a treatment option for severe systemic sclerosis?
    van Laar JM, Farge D, Tyndall A.
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii35-8. PubMed ID: 19022811
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation.
    Stewart DA, Guo D, Glück S, Morris D, Chaudhry A, deMetz C, Klassen J, Brown CB, Russell JA.
    Bone Marrow Transplant; 2000 Aug; 26(4):383-8. PubMed ID: 10982284
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.